Cholecystitis associated with Q fever: case report and systematic review
- PMID: 40629112
- PMCID: PMC12484248
- DOI: 10.1007/s10096-025-05193-7
Cholecystitis associated with Q fever: case report and systematic review
Erratum in
-
Correction to: Cholecystitis associated with Q fever: case report and systematic review.Eur J Clin Microbiol Infect Dis. 2025 Sep 1. doi: 10.1007/s10096-025-05237-y. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2025. PMID: 40889070 No abstract available.
Abstract
Background: Coxiella burnetii is an underestimated cause of acalculous cholecystitis. Large studies recently allowed to identify a dose-dependent association with IgG anticardiolipin. The management and long-term complications of Q fever-associated cholecystitis remain to be determined.
Methods: We describe a surgical case from Martigues, France, which is an endemic area and performed a systematic review of C. burnetii cholecystitis cases associated with Q Fever.
Results: Twenty-seven patients were included, including 3 (11.1%) children. All cases were reported during acute Q fever, followed by recurrent pancreatitis and chronic cholecystitis in 1 (3.7%) case. Two (2/2, 100%) were proven by a positive PCR on gallbladder but immunohistochemistry was negative in all cases. Only 3 (11.1%) cases were calculous. Coxiella burnetii cholecystitis is atypic because it is acalculous, with a flu-like syndrome, lupus anticoagulant, anticardiolipin antibodies and thrombocytopaenia.
Conclusions: Serology and PCR from blood and gallbladder biopsies are key to the aetiological diagnosis of C. burnetii cholecystitis. Inflammatory and/or autoimmune mechanism is suspected. Doxycycline remains the first-line therapy. Future prospective studies should determine whether treatment with doxycycline and hydroxychloroquine can prevent the chronic evolution of the disease in patients who initially present with antiphospholipid antibodies.
Keywords: Acalculous; Cholecystitis; Coxiella burnetii; Q fever.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Gallaher JR, Charles A, Acute Cholecystitis Rev JAMA 2022 8;327:965. 10.1001/jama.2022.2350 - PubMed
-
- Barie PS, Eachempati SR (2003) Acute acalculous cholecystitis. Curr Gastroenterol Rep 5:302–309. 10.1007/s11894-003-0067-x - PubMed
-
- Date K, Shirai Y, Hatakeyama K (1997) Antiphospholipid antibody syndrome presenting as acute acalculous cholecystitis. Am J Gastroenterol - PubMed
-
- Nolen B (1999) Warmberg, nouts, ley, slama. Acute acalculous cholecystitis associated with primary antiphospholipid antibody syndrome. Cure with low-molecular-weight heparin and antivitamin K. Gastroenterol Clin Biol - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources